Response of advanced breast carcinoma to the combination of the antimetabolite, Methotrexate, and the alkylating agent, thio-TEPA.
D000477:Alkylating Agents; D000963:Antimetabolites; D001943:Breast Neoplasms; D006801:Humans; D008727:Methotrexate; D013852:Thiotepa
D000477:Alkylating Agents; D000963:Antimetabolites; D013852:Thiotepa; D008727:Methotrexate
BREAST NEOPLASMS; METHOTREXATE; THIO-TEPA